Physician profile
Jennifer Ann Mittlestead
NPI 1295024131
$8,646.30
in general payments reported to CMS, 2019-2025
48 companies · $1,165 in 2025
The $1,165 reported for 2025 was more than what 93% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $984 · 2020: $785 · 2021: $1,005 · 2022: $1,823 · 2023: $1,665 · 2024: $1,219 · 2025: $1,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,924 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,924.31 |
| Education | $124.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,195.90 | 2020-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $854.73 | 2019-2025 | |
| Amgen INC. | $628.26 | 2019-2025 | Evenity, Prolia |
| Gynesonics, INC. | $587.88 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $539.04 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $388.30 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $369.67 | 2022-2025 | |
| Hologic Sales and Service, LLC | $327.79 | 2019-2024 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Therapeuticsmd, INC. | $286.33 | 2019-2022 | |
| Currax Pharmaceuticals LLC | $283.96 | 2019-2023 | Contrave, Nexletol, Nexlizet |
| Coopersurgical, INC. | $266.39 | 2019-2025 | Paragard T 380a, Paragard T 380a, Supercut Hysterectomy Scissors |
| Agile Therapeutics, INC. | $206.41 | 2021-2023 | Twirla |
| Myovant Sciences INC. | $194.99 | 2021-2022 | |
| Biogen, INC. | $188.65 | 2024-2025 | Zurzuvae |
| Aspira Women'S Health INC | $185.16 | 2020-2024 | Ova1 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $176.69 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $162.91 | 2019-2024 | Gardasil 9, Gardasil |
| Novo Nordisk INC | $148.34 | 2020-2024 | Wegovy |
| Organon LLC | $143.46 | 2021-2025 | Nexplanon |
| Millicent US INC | $137.95 | 2024-2025 | Femlyv, Intrarosa |
| Daiichi Sankyo INC. | $128.04 | 2019-2022 | |
| Medicem INC. | $110.06 | 2021 | |
| Pfizer INC. | $99.73 | 2019-2024 | |
| Ethicon US, LLC | $98.09 | 2020-2023 | Ethicon, Dermabond |
| Avion Pharmaceuticals | $93.25 | 2020-2022 | |
| Optumhealth Care Solutions, LLC | $88.49 | 2023-2025 | Eitan Medical, Vivify Health Care Team Portal 001, Zyno Solutions |
| Mylan Pharmaceuticals INC. | $86.25 | 2021-2022 | |
| Myriad Women'S Health, INC. | $78.80 | 2023 | Myrisk |
| Scynexis, INC. | $69.99 | 2022 | |
| Meditrina | $65.40 | 2022-2025 | |
| Evofem Biosciences, INC. | $60.35 | 2021-2022 | |
| Lupin INC. | $52.45 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.13 | 2020-2025 | |
| Dysis Medical, INC. | $34.89 | 2022 | |
| Convatec INC. | $32.71 | 2022-2023 | |
| Exact Sciences Corporation | $27.13 | 2025 | Cologuard Collection Kit |
| Medtronic Minimed, INC. | $24.25 | 2019 | |
| Roche Diagnostics Corporation | $23.39 | 2019 | |
| Avanos Medical | $20.33 | 2025 | On-Q Pump and Accessories |
| Lilly USA, LLC | $19.74 | 2025 | Zepbound |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Amag Pharmaceuticals, INC. | $16.74 | 2019 | |
| Sage Therapeutics, LLC | $15.14 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $12.43 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.32 | 2019 | |
| Olympus America INC. | $11.93 | 2019 | |
| Bausch Health US, LLC | $11.54 | 2019 | |
| Mission Pharmacal Company | $10.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mittlestead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.